
This is the most comprehensive primary-source atlas of European lower-middle-market private equity buyers we have published. The objective is to give an LMM company owner, advisor, or LP a verified map of every named sponsor that actively acquires sub-€500M EV companies across the seven European regions, anchored in primary publications from Invest Europe, the national venture-capital associations (BVCA, France Invest, SVCA, DVCA, FVCA, NVP, BVA, SpainCap), the Argos Mid-Market Index, EU regulatory bodies, sponsor press releases, and sponsor portfolio pages. Each named platform carries an explicit confidence rating (HIGH, MEDIUM, LOW), and gaps are disclosed rather than filled with consultant consensus.
The LMM scope for this memo is sub-€500M enterprise value, with most sponsors clustering in the €20M-€200M EV band. We profile mega-cap European PE only insofar as they have explicit LMM sub-funds (Hg Mercury, IK Small Cap, Triton Smaller Mid-Cap, PAI Mid-Market, Ardian Expansion, Eurazeo Smid-Cap, Astorg Mid-Cap, Bridgepoint Development Capital, Carlyle Europe Technology Partners, EQT Mid Market Europe). Mega-cap large-cap funds are referenced only for context (deal-flow anchoring + IPO-exit market).
Primary sources cited inline include the Invest Europe Activity 2024 and 2025 reports, Invest Europe Capital Under Management and Dry Powder 2024, the Argos Mid-Market Index quarterly publications, the BVCA / UK Private Capital 2025 Investment Activity Report and Performance Measurement Survey 2024, the France Invest 2024 + 2025 activity data, the SpainCap (ASCRI) 2024 industry data (via Chambers 2025 Spain guide where the primary website returned TLS cert errors), the NVP Netherlands 2024 market data, the FVCA Finland 2025 data, the SVCA Sweden 2025 reports, the KfW Research succession monitoring, the Bpifrance Le Lab transmission survey 2025, the European Commission Foreign Subsidies Regulation guidelines (9 January 2026), the EU AI Act phased implementation timeline (1 August 2024 to 2 August 2028), the SFDR2 proposal (20 November 2025) and CSRD Omnibus I package (provisional agreement 9 December 2025, Parliament approval 16 December 2025), plus 100+ sponsor and platform press releases verified directly from primary sources.
What this memo will not assert: per-deal LMM multiples for individual sub-€100M tuck-ins that sponsors do not disclose; CEE-specific 2025 fundraising as a standalone percentage of European total (Invest Europe’s regional split publishes France & Benelux + UK & Ireland + Southern Europe + DACH + Nordics, with CEE inside one of those buckets); the precise 2025 deal-completion count for European succession deals (no consolidated EU-wide tracker exists comparable to KfW’s German-specific monitoring); SFDR-failed deal counts (no named 2024-2025 case located in primary sources where a PE transaction failed specifically due to SFDR diligence); and quantified premium attributable to ESG / Article 9 fund classification in deal pricing.
The 2024-2026 European PE market is defined by a paradox: record fundraising despite compressed deal multiples. The data:
The Argos Mid-Market Index quarterly publications anchor the multiples picture:
| Quarter | Eurozone Mid-Market EV/EBITDA | Note |
|---|---|---|
| Q1 2024 | 8.9x | “declined slightly” |
| Q3 2024 | 9.5x | “recovered” |
| Q4 2024 | 9.8x | +3% QoQ |
| Q1 2025 | 9.5x | -3% QoQ; PE multiples 10.0x, strategic 9.2x |
| Q2 2025 | 9.2x | -3% QoQ; strategic buyers dropped to 8.5x; M&A volume -20%, value -35% vs Q4 2024 |
| Q3 2025 | 8.7x | -5.4% QoQ; lowest level since Q1 2017 |
| Q4 2025 | 8.3x | -4.6% QoQ; lowest level since H1 2014; deals below 7x at record 27%, deals above 15x at record-low 7% |
| Q1 2026 | 8.6x | Recovered slightly, supported by prices paid by investment funds; PE 10.0x, strategic 7.8x (spread widened to 2.2x) |
Confidence: HIGH on every Argos data point (primary publisher). The structural finding from our companion European SME Succession Wave 2026-2030 memo is confirmed: the succession wave is landing into a compressed-multiple environment, not an expanding-multiple one.
The European succession wave is the single most important demographic tailwind under the LMM PE deployment thesis. Six European economies publish country-level 2030-horizon succession projections in formats credible enough to cite directly. Aggregated, they describe approximately 3.58 million SMEs in succession scope by 2030 across the United Kingdom, Germany, Italy, Spain, France, and Switzerland.
Combined: approximately 3.58 million SMEs in succession scope by 2030 across these six countries. Read against Invest Europe’s €278B European buyout dry powder, that implies ~€78,000 of dry powder available per succession-scope SME, before accounting for the share that will close rather than transfer, the share that will trade strategically rather than to PE, and the share that falls below the €5M EBITDA threshold most LMM platforms underwrite. The arithmetic is directional, not predictive, but the order of magnitude makes the LMM deployment opportunity explicit.
Gap disclosure. Sweden, Netherlands, Belgium, Denmark, Poland, and other European economies sit on the same demographic curve but do not publish country-level 2030 succession projections in formats comparable to KfW, Bpifrance, UBS-HSG, or Confindustria. The European Commission DG GROW / Eurostat policy frame estimates approximately 450,000 firms transferred annually across Europe with ~2 million employees involved, and approximately 150,000 European businesses annually at risk of not finding a successor, but the precise primary-publication vintage is older than 3 years and the methodology is not directly comparable to the country-level studies above. Confidence on the Eurostat frame: MEDIUM.
The UK is the single largest European PE market by fundraising (€50.4B in 2025) and has the deepest specialist LMM sponsor pool of any European region. BVCA / UK Private Capital data tells the structural story: UK Small PE returned 9.0% in 2024 versus Large PE at 2.4%, the highest segment-level differential in the BVCA Performance Measurement Survey 2024. UK LMM resilience is data-confirmed, not anecdotal. Source: BVCA Performance Measurement Survey 2024. Confidence: HIGH.
UK 2025 fundraising reached £58.7B, the third-highest year on record (vs £34.8B in 2024). 2025 investment activity: £25.0B into UK companies, 1,434 UK companies, 9 of 10 going to SMEs, 57% outside London. 2.5M people employed by PE/VC-backed UK companies; 13,000 businesses backed by UK PE/VC. Source: UK Private Capital Report on Investment Activity 2025. Confidence: HIGH.
| Sponsor | HQ | Latest fund | EV / equity ticket band | Sector focus | Recent platform deals 2024-2026 |
|---|---|---|---|---|---|
| Inflexion Private Equity | London | Buyout Fund VII closed March 2026 at €4.5B hard cap; AUM ~€20B; Partnership Capital (minority) + Enterprise Fund (LMM) | EV €250M-€1B (Buyout); Partnership for smaller | Business Services, Tech, Financial Services, Healthcare, Industrials, Consumer | Marioff (fire safety), Marktlink Capital minority, Celnor (compliance) |
| LDC (Lloyds Development Capital) | London + 10 UK regional offices | Evergreen balance sheet from Lloyds Banking Group | up to £100M per investment | Diversified UK regional | £450M deployed across 17 new + 49 portfolio bolt-ons in 2024 (£1.2B 3-year total). Named: Pagabo (Hull built-env software), IDSL (Mansfield), Medray (Dublin healthcare), Deltron Group, Waterscan, 15below, AppCheck, BCIS, Sedex (exited 2025) |
| BGF (Business Growth Fund) | London + UK regional | Evergreen, bank-backed (£2.5B; 2025 commitment of £3B over 5 years; cumulative £4.5B+ across 600+ companies) | £1M-£15M initial, minority only | All-sector SMEs + Deep Tech / Life Sciences | Hydrock exited 2024 to Stantec; Gaussion, DEScycle active |
| August Equity | London | August Equity Partners VI closed September 2024 at £350M hard cap | UK / Ireland LMM primary buyouts | Essential services, B2B software (compliance, education, healthcare) | 40+ platforms, 175+ bolt-on acquisitions across Funds IV-VI; One Touch (April 2026), Impact Futures Group (March 2026) |
| Livingbridge | London | Livingbridge 7 closed 2021 at £1.2B hard cap | equity up to £150M in high-growth, EV up to £300M | Technology, Services, Healthcare & Education, Consumer | 250+ portfolio cumulative; World of Books active |
| ECI Partners | London + Manchester + NY | ECI 12 closed September 2023 at £1B hard cap (vs £700M ECI 11); 95% re-up rate | UK mid-market PE | Growth businesses (sector-agnostic) | Helio Intelligence (May 2026) |
| Bowmark Capital | London | Bowmark Capital Partners VII closed January 2024 at £900M hard cap (50% larger than predecessor); £2B FuM | up to £200M equity per investment | Data & Insight, Managed IT Services, Software, Tech-enabled Business Services | BCIS (May 2026), ASK4 |
| Synova Capital | London | Synova V closed July 2022 at £875M hard cap (incl. £250M Chrysalis pool for smaller deals); £1.7B+ managed | Two-tranche fund for size flexibility | Technology, Business Services, Financial Services, Health & Education | Defaqto, Mintec, MeritSoft, National Education Group, JMG Group |
| WestBridge Capital | London + Manchester + Cardiff | WestBridge III closed at £220M hard cap (2x predecessor); +£34m commitment 2026 | Up to £200M of capital; targets £2M-£8M EBIT companies | B2B in growing niches (sector-agnostic LMM) | Tryzens, Survey Solutions, Causeway Securities, KOTO (Fund III); AJM Healthcare, LinkFresh, APEM (legacy) |
| Apiary Capital | London | Apiary Capital Partners II closed April 2024 at £240M (target £200M) | Consolidation platforms in fragmented markets | Business, financial, technology, education, healthcare services | Radiant (three add-on acquisitions); LearnPro Group acquired KIM Software Solutions |
| Mobeus Equity Partners | London | Current fund size not publicly disclosed (gap-disclosed) | up to £25M into companies with £2-7.5M EBITDA | B2B Services, Human Capital, Distinctive Brands | G=mc2 (£15.8M MBO), Big Potato Games (£16.2M MBO), Distant Journeys (£15.2M MBO), Ellis Recruitment (£9.5M equity release), Intralink (£19.6M equity release) |
| Endless LLP | Leeds | Endless Fund V closed November 2020 at £400M; Enact Fund III £100M (smaller LMM) | Endless V revenue band £50M-£1B; Enact III revenue £10M-£50M | Food & Beverage, Industrials, Business Services, Consumer (Family-Owned, Carve-Out, Complex Buy-Out, Special Situations) | Veloris (ex-Ecobat Battery), ASCO, Hovis, KTC Group, Bright Blue Food |
| Connection Capital | London | HNW investor syndication platform; £527M+ raised cumulatively | £3M-£10M for MBOs | Sector-diversified UK LMM | Virgin Wines, Tempcover, Carter Accommodation, Impero, TeamSport Karting, 23.5 Degrees; co-invest with CVC, 17Capital, InvestIndustrial, Enact |
| Phoenix Equity Partners | London | September 2024 launched flagship + Growth Partnership Fund (combined £600M+) | £10M-£80M equity cheques | Data & Analytics, Technology & Specialist Services, Health & Wellbeing | Nineteen Group (Peter Jones), Travel Chapter, Sygnature Discovery, 1000heads |
Confidence on every row: HIGH, with one MEDIUM on Mobeus (fund size not publicly disclosed) and one MEDIUM on Phoenix (combined fund detail thin).
HCAP referenced in many European PE rosters is a US firm (Southern California), not an Irish entity. The genuine Irish LMM specialists are:
Brexit recovery directional: cross-border UK-EU M&A share rebounded to 42% of European deal volume in 2024 (vs 38% in 2004), helped by the May 2025 UK-EU Summit and mutual recognition agreements on conformity assessment. UK PE deal volumes fell 10.2% in 2025 overall, but mid-market volumes remained fairly stable, confirming the BVCA’s small-segment performance differential. Confidence: MEDIUM directional.
France is the largest Continental European PE market and has the largest LMM-specialist pool by sponsor count. France Invest 2024: fundraising €38.9B (+9% YoY); investments €36.9B across 2,881 companies / infrastructure projects (+13% YoY); exits €12.8B across 1,316 transactions (+42% YoY). France Invest 2025 preview: fundraising €42.9B (+10%) = historic high; investments €36.4B (-1% vs 2024 = first decline). Source: France Invest activity report 2024. Confidence: HIGH.
Per Bpifrance Le Lab transmission survey (5,000+ respondents, 2025): 370,000 French firms in transmission scope by 2030 (310,000 TPEs + 58,000 SMEs + 1,200 ETIs covering ~3M jobs). At current run-rate only 130,000 will actually transmit, implying potential 3x current volume. 40% of all leaders intend to transmit within 5 years (40% TPEs / 36% SMEs / 23% ETIs). Confidence: HIGH.
| Sponsor | HQ | Latest fund | Equity tickets / EV band | Sector / style |
|---|---|---|---|---|
| Andera Partners | Paris (Madrid office 2024) | Andera MidCap 5 closed September 2023 at €750M hard cap (vs €445M predecessor); MidCap 6 in fundraising. AUM ~€4.5B end-2024 | Equity tickets €30-€100M (MidCap 5) | Generalist with healthcare / business services / industrial bias; LMM growth companies; control buyouts |
| Activa Capital | Paris | €450M+ under management | Generalist French LMM | Control buyouts, entrepreneur-aligned. 2024-26: ARCHE MC2 (May 2026), GO! Formations/Quali-Forme (March 2026), DESEGUR Group (March 2026) |
| 21 Invest France | Paris | 21 Invest France VI (2023 vintage); group AUM ~€1.5B (Italy + France + Spain); Iberia office opened 2024 | Category champion / growth catalyst | Healthcare, Tech/Software, Business Services |
| IK Partners | Paris + Stockholm (HQ Amsterdam) | IK Small Cap IV at €2.0B (2025); Development Capital €600M; flagship IK X €3.3B | Mid Cap €200M+; Small Cap €80-€200M; Dev Cap €20-€80M | Business Services, Healthcare, Industrials |
| Argos (formerly Argos Wityu) | Paris (6 European offices) | Argos Mid-Market VIII targeted €450M; Argos Climate Action closed oversubscribed | Portfolio EV range €12M-€582M | Active ownership; Diane-strategy turnaround DNA historically; ESG / SBTi committed. AUM €2.3B group-wide |
| Naxicap Partners | Paris (Benelux/Germany/Spain expansion) | NIO III final closing May 21, 2026; AUM multiplied by 15 over 15 years | Mid-cap €50M-€200M EV; Small Caps €5-€30M; Innovation & Growth up to €5M | 80% control/majority. 2024-26: Solutys build-ups (Sept 2025); APF Autoparts (July 2025); ADDEV Materials (July 2025) |
| Capza (AXA IM Alts) | Paris (offices Spain, Germany, Italy) | Capza 5 Flex Equity final close at €700M hard cap; total AUM >€9B (March 2024) | Flex – majority OR minority + convertible bonds + mezzanine | Lower-mid-cap SMEs France, Spain, Germany, Italy |
| Eurazeo PME | Paris | Eurazeo PME V first close at >€1B (announced May 20, 2026, Tech & Services focus); predecessor PME IV ~€1B (2022) | French SMEs with €10-€20M EBITDA (PME IV) | 10%+ already deployed; targeting 15+ portfolio companies; international LPs 60% of commitments. Initial: OMMAX, Nextron Systems |
| Initiative & Finance | Paris | Initiative & Finance FPCI III final close €200M hard cap (vs FPCI II €165M, 2015); AUM >€500M | SME team €3-€20M tickets; TOMORROW team (environmental transition) €20-€80M | French SMEs |
| Bpifrance | Paris (state-backed) | ETI 2020 fund €3B (formed 2013); Mid Cap fund family ~€1B AUM; total direct equity deployment €2-€3B/yr across 1,100+ holdings; fund-of-funds dry powder record €30B in 2024 | ETI minority equity in transactions >€10M; Mid Cap tickets €5-€30M | French ETI, mid-cap, growth, regional development |
| Cathay Capital | Paris + Shanghai + NY | Cathay Small Cap IV final close €240M (June 29, 2023); group AUM $5.5B+ | Equity tickets €15-€30M, mainly minority alongside founders | Healthcare, software, consumer, education (Sino-European-US strategy) |
| Sagard NewGen | Paris + Montreal | NewGen I (2020-vintage); NewGen II upcoming (size not yet disclosed) | €10-€50M tickets; max €150M revenue targets | IT/healthcare buyout; Bridewell (Feb 2025), FuturMaster (Oct 2024), I-Tracing exit to Oakley (June 2024) |
| Five Arrows Principal Investments (Rothschild & Co) | Paris + London + NY | FAPI IV $2.83B / ~€2.6B (2022); FAPI III €1.41B; Five Arrows Debt Partners IV €2.4B (Sep 2025); Six secondaries fund €2B (April 2025) | Mid-cap European | Tech, healthcare, services |
| Capital Croissance | Paris (+ Lille, Aix-en-Provence) | AUM €950M (May 2024) | Equity tickets €1-€50M per transaction | French LMM |
| Ekkio Capital | Paris | Ekkio IV closed €161M end-2017; current AUM €250M | French LMM | Sector-diversified |
| PAI Mid-Market Fund | Paris | PAI Mid-Market Fund I ~€920M (2023 final close); Fund II in market, first investment 6-Nov-2025 | Mid-market European | Food & consumer, business services, industrials, healthcare |
| Astorg Mid-Cap | Paris (Luxembourg domicile) | Astorg Mid-Cap (inaugural) closed €1.3B hard cap February 2022; targets €100-€400M EV; Astorg VIII (flagship) €4.4B (May 2024) | €100-€400M EV (Mid-Cap) | B2B global niche leaders |
| Tikehau Capital | Paris | Climate AUM €5.8B end-2025 (+42% YoY); Decarbonization Fund II latest vintage | Climate / energy transition | Climate, decarbonization, cybersecurity (Brienne sub-strategy) |
Confidence on every row: HIGH on sponsor structure and fund size, MEDIUM on per-deal pricing (rarely disclosed for sub-€100M tucks).
The DACH LMM PE landscape is profiled in detail in our companion Private Equity Firms in Switzerland & DACH 2026 memo. Key data points to anchor pan-European context:
Named DACH LMM sponsors covered in the companion memo include Equistone, Capvis, Ufenau Capital Partners (Ufenau VIII Asset Light closed €2.12B in under 4 months June 2025), DPE Deutsche Private Equity, Afinum, AUCTUS Capital Partners, EMERAM Capital Partners, Maxburg Capital Partners, Quadriga Capital, ECM Equity Capital Management, Argos in DACH, Triton from its Frankfurt office, and the Swiss Polaris Partners Group / Capvis cluster.
Nordics 2025 fundraising: €8.5B per Invest Europe regional split. Finland alone hit a record €4.6B in 2025 investments per FVCA. The Nordic LMM landscape divides into three structural archetypes:
| Sponsor | HQ | Latest fund | EV / equity ticket band | Sector / style |
|---|---|---|---|---|
| Adelis Equity Partners | Stockholm | Fund IV closed 28 February 2025 at €1.616B (€1.5B external + €116M GP); 2024 vintage | Nordics + DACH; 8 platforms, 300+ add-ons cumulative | Business Services, Tech & Software, Healthcare & Life Sciences; control buyouts |
| Verdane | Oslo (multi-Nordic) | Verdane Edda III closed February 2024 at €1.1B (2x predecessor); Idun II €700M hard cap; total €2.2B raised in 6 months | €20-€150M tickets | Digitalisation, decarbonisation; growth equity (majority + minority flexible) |
| IK Small Cap IV | Paris + Stockholm (HQ Amsterdam) | IK Small Cap IV closed 24 July 2025 at €2.0B hard cap (oversubscribed in 6 months) | €80-€200M EV (Small Cap); Development Capital €20-€80M | Business Services, Healthcare, Industrials |
| Norvestor | Oslo (Nordic-wide) | Norvestor IX closed November 2023 at €1.5B hard cap (vs target €1.25B; predecessor €806M) | Revenues €20-€300M | Tech-Enabled Services, Business Services, Industrial Solutions & Services; control buyouts; 4-6 year hold |
| Axcel | Copenhagen | Axcel VII closed February 2024 at €1.3B hard cap (60% larger than predecessor); Axcel Elevate Fund I closed at €459M hard cap (dedicated lower mid-market) | Mid-market and LMM | Technology, Industrials & Business Services, Healthcare, Consumer; 2024-26: Sanviva (Jun 2026), Geomatikk Group (Mar 2026), Sangro (Mar 2026) |
| FSN Capital | Multi-Nordic + DACH offices | FSN Capital VI €1.8B (vintage 2021); FSN Capital Compass Fund (purpose-driven, target €400M+) | Northern European mid-market | Buyouts; Compass focused on purpose-driven companies |
| Polaris Private Equity | Copenhagen | Polaris V launched 2021 with €650M commitment; Polaris Flexible Capital I launched 2022 | Nordic mid-sized | Sector-agnostic; control + minority + listed strategies |
| Procuritas | Stockholm | Procuritas Capital Investors VII | Nordic LMM | Multi-sector (e-commerce, care, building automation, parking/mobility). 2024-26: EuroPark Finland (June 2026), Parkman Sweden (Sept 2025), Netcontrol divested to ABB (Dec 2025) |
| CapMan | Helsinki | AUM €7.2B across PE + RE + Infra + Natural Capital + Real Asset Debt; Buyout XII active | Finnish mid-market with LMM activity | Multi-strategy Nordic platform. Portfolio: Eural, PDS Vision, Unikie, Valokuitunen, Forenom, Fennoa, Niemi |
| Vaaka Partners | Helsinki + Stockholm | Vaaka Partners Buyout Fund IV closed at €250M (oversubscribed in 11 weeks, 2023) | Medium-sized Finnish companies (sector-agnostic LMM) | Control buyouts; 2024-26: Eltrea (May 2026), AINS Group (March 2026) |
| Sponsor Capital | Helsinki | Sponsor Fund VI closed at €231M (first and final closing) | Finnish LMM (€10-€50M EVs) | Finnish SMEs (buyout + growth) |
| Trill Impact | Stockholm | AUM €1.4B; Trill Impact II (open, buyout); Ventures Fund €90M+ (Life Sciences + Green Tech) | Mid-sized Northern European buyout with impact mandate | Sustainable Planet, Resilient Society, Healthy People. 2024-26: Noova Energy Systems (Dec 2025 majority) |
| Triton Smaller Mid-Cap Fund | Frankfurt + Stockholm | TSM I €448M (2017); TSM II €815M; TSM III rumored ~€1B target | Sub-€100M to €300M EV LMM | Industrial tech, business services, healthcare; explicit LMM fund within Triton |
| Storskogen (UNIQUE) | Stockholm (NASDAQ Stockholm listed) | Publicly-listed permanent capital; 114 business units; ~10,500 employees | Permanent-capital LMM holding | FY 2025: SEK 33,097M revenue; SEK 3,117M adjusted EBITA (9.4% margin); 2025 deal pace: 3 platforms + 6 add-ons. Only Nordic Nasdaq-listed permanent-capital LMM acquirer at scale |
Netherlands 2024 PE buyouts: €5.8B invested in 111 Dutch companies (vs €4.7B / 122 deals 2023); 63 Dutch companies sold in 2024 (highest since 2021). Source: NVP Netherlands 2024 market data. Confidence: HIGH.
| Sponsor | HQ | Latest fund | Style / sector |
|---|---|---|---|
| Waterland Private Equity | Bussum, NL | WPEF IX €3.5B + Partnership Fund I €500M = €4B closed in 4 months (October 2024); both at hard cap | Buy-and-build in fragmented European growth markets. Themes: Ageing Population, Digitalisation, Leisure & Wellbeing, Sustainability |
| NPM Capital (SHV Holdings) | Amsterdam (+ Ghent + Munich) | Evergreen, owned by SHV Family of Companies since 2000 | Equity ticket €30-€300M; 26 portfolio companies. Themes: Digital & Technology, Healthy Life & Learning, Feeding the World, Sustainable Future |
| Bencis Capital Partners | Amsterdam (+ Brussels + Düsseldorf) | AUM ~€2.3B combined portfolio turnover; 30 companies, 13,235 employees | Benelux + DACH |
| Egeria | Amsterdam | 6th PE fund €1.25B; Egeria Evergreen €700M (10+ year holds) | PE EV range up to €500M; Evergreen platforms €300-€500M EV. Benelux + DACH (PE); Europe + N. America (Evergreen) |
| Gilde Equity Management (GEM Benelux) | Antwerp + Naarden | GEM VI closed June 2025 at €600M hard cap; oversubscribed | EV range €20-€200M per transaction |
| Mentha Capital | Amsterdam | Mentha VII $303M (2022); Mentha Impact Fund I €153M final close October 2024 (oversubscribed) | Benelux + Denmark middle market in sustainable process technology + energy transition |
| Karmijn Kapitaal | Amsterdam | Karmijn III €100M target (announced June 2023) | Gender-diverse leadership teams in Dutch SMEs |
| Holland Capital | Amsterdam + Düsseldorf | Fund size not publicly disclosed (gap-disclosed) | Technology (IT services, software, agrifood tech, energy transition) + Healthcare. 2024-26: Kids Lodge / Jansen & Jansen, KinderThuisZorg, Medexs/Van Vliet/Laméris, Sibi, HuisartsenHulp, CareAbout |
| Sofindev | Diegem, Belgium | Sofindev VI closed December 2022 at €250M (vs V €170M, 2019; IV €107M, 2015) | Tickets €5-€30M; Belgium + Luxembourg + Netherlands |
| Indufin | Heverlee, Belgium | Belgian open-ended evergreen investment fund | Companies with EBITDA ≥ €2M; equity tickets €5-€15M; strong minority preferred. Belgium + Luxembourg |
| Smile Invest | Den Haag + Leuven | Open-ended evergreen, ~40 entrepreneurial families as LPs; AUM €350M | Digitalisation, healthcare & wellbeing, sustainability |
| Ackermans & van Haaren / Sofinim | Antwerp (Euronext Brussels: ACKB) | Permanent-capital diversified holding company | Multi-strategy permanent capital; Belgian + global |
| Vortex Capital Partners | Amsterdam | 29 portfolio companies / 9 acquisitions (as of January 2026) | Software and digital technology in Netherlands + Belgium |
Per SpainCap (ASCRI) via Chambers 2025 Spain guide (primary SpainCap site returned TLS cert errors): Spain 2024 total PE/VC investment €6.538B (-2.6% YoY) across 725 transactions (vs 844 in 2023). 2024 divestments: +113% YoY to 211 exits totalling €2,902M (vs €1,362M). Confidence: MEDIUM via secondary citation. Foreign-manager investment volume in Spain: -5% in 2024 vs 2023.
| Sponsor | HQ | Latest fund | Style / sector |
|---|---|---|---|
| MCH Private Equity | Madrid | MCH Iberian Capital Fund VI registered with CNMV, target ~€500M, cap €600M, 24-month fundraising; MCH V (2020) | Spain + Portugal mid-sized growth companies |
| Portobello Capital | Madrid + Luxembourg | Fondo IV €600M; Fondo V registered with CNMV (DFI May 2025); group AUM €3.7B | 2024-26: BLUESEA Hotels, Dualparts, Proeduca, Clínicas Mi, Plexus, Plenergy, Controlauto, Solions, Torre Oria, Serveo |
| Nazca Capital | Madrid | >€1B AUM across 10 vehicles, 116 transactions; >90% family-business focus | Aerospace & Defence, Small Caps, Selective Investments. 2024-26: Teltronic (May 2026), Grupo Oesía minority (April 2026), Zunibal continuation fund, PLD Space Series C €180M (March 2026) |
| Realza Capital | Madrid | >€335M AUM (Realza I €170M, Realza II €165M) | ~90% family businesses; Spanish middle-market |
| Diana Capital | Madrid | Diana Capital III FCR target €200M, final close ~€180M | Spanish middle-market, sector-agnostic, growth + international expansion |
| Buenavista Equity Partners | Madrid + Lisbon | AUM ~€1B across PE + VC + Infrastructure vehicles | Majority stakes; proprietary deal flow >2/3 of transactions. 2024-26: SOKAI €64.5M life-sciences hub (May 2026), Instituto Bernabeu (May 2026), Evidenze Group exit to Columna Capital (May 2026) |
| ProA Capital | Madrid | ProA Buyout Fund IV in market, first investments Q3 2024 (BAT Group, Nutrición Médica) | Family-run market-leaders, majority stakes (e.g. 70% Avioparts, majority Acrylicos Vallejo). 2025 named exit: Avioparts sold to Proponent ~€100M (October 2025) |
| Sherpa Capital | Madrid | >€350M across 4 funds; 15+ year track record | Transformational / turnaround / carve-outs / succession Spain + Portugal SMEs. 2024-25: Koxka (June 2025), EQOfluids majority, FlyBy, Transnugón, BPXport/LUDE |
| Oquendo Capital | Madrid | Oquendo Mezzanine IV target €250M / hard cap €300M (Nov 2019) | Mezzanine + equity, growth/buyout/recap/loan |
| Black Toro Capital | Barcelona | 4 funds total; Fund III €350M target | Structured capital for Spanish mid-cap |
| Magnum Capital Industrial Partners | Madrid | Magnum III $513M (2020); Magnum IV launched January 2026; finalizing new fund up to €500M as of December 2025 | Spain + Portugal industrial |
| Explorer Investments (Portugal) | Lisbon | AUM €1.5-€1.8B across 4 strategies (PE, Growth, Tourism, Real Estate); 4 funds >€450M capitalization | Buyouts, Growth, Hospitality. Named portfolio: Micronipol, BHOUT, Octant |
| Iberis Capital (Portugal) | Lisbon (Porto office opened Sept 2025) | AUM >€600M / >1,300 investors | Innovation & growth + yielding investments |
Italy’s LMM PE landscape has been reshaped in 2025-2026 by three structural events: (a) Green Arrow Capital signed binding agreement to acquire 100% of DeA Capital Alternative Funds SGR from De Agostini Group (August 5, 2025), creating a >€6B AUM combined entity; (b) Edizione (Benetton family holding) + 21 Invest + Tages formed 21 Next in December 2025 with ~€3B combined AUM targeting €10B in 5 years; and (c) Xenon Private Equity announced binding agreement to join EQUITA’s alternative-asset platform, contributing ~€1B AUM. Confidence: HIGH on all three.
Confindustria’s GenerAZIONI 2026 survey covers the Italian succession backdrop: ~1 million PMI face succession in next 10 years; ~23% of family-business leaders are over 70; only ~15% of successions are formally planned. Source: Confindustria GenerAZIONI 2026. Confidence: HIGH.
| Sponsor | Position | Latest fund | 2024-2026 highlights |
|---|---|---|---|
| Italmobiliare | Permanent capital holding | NAV €2,304.9M ex-treasury (31 Dec 2025) | Portfolio: Caffè Borbone (FY2025 revenue €370.8M, +10.8%, EBITDA €56.8M), Officina Profumo-Farmaceutica di Santa Maria Novella, CDS-Casa della Salute, Italgen, SIDI Sport, Capitelli, Tecnica Group, Iseo, Bene Assicurazioni, Clessidra Holding |
| Clessidra Capital Partners | Italmobiliare-owned | CCP IV (2021 vintage, $305M); ticket EUR 40-100M, EV EUR 100-500M | €2.3B invested since 2003. 2024-26: Molino Nicoli, Everton Tea House, Impresoft Group |
| Charme Capital Partners | Italian pan-European | Charme IV €850M (2021) | 17 portfolio companies (Italy 8, Spain 4, UK 2). 2025: Centogene; Bianalisi add-ons Lucea + Nobiliore Diagnostic Centers |
| Wise Equity (Wisequity) | Italian LMM pure-play | Wisequity VI active | 2024-26 platforms: Fas (2026), Marullo / pistachio (2025), Absolute yachts, Casa della Piada, Greenexta / ag-inputs, MEP Macchine Elettroniche Piegatrici |
| Ambienta SGR | Sustainability specialist | PE AUM €3.2B; Ambienta IV mid-cap €1.55B; latest small-cap raise €500M | Tickets €30-€300M; Small Cap EV €50-€150M; Mid Cap EV €100-€300M; 43 investment professionals; consolidated portfolio EBITDA c. €530M |
| Investindustrial | Italian-European mid-cap | Investindustrial VII (widely cited at €4B 2022; not on primary site) | 2025-26: TACH Systems Group (May 2026), TreeHouse Foods (Nov 2025), Fatro (Sept 2025), DEA Group + EL.MO. (Sept 2025), Kiremko/Idaho Steel/Reyco (Aug 2025) |
| Stirling Square Capital Partners | UK pan-European; Italy is largest country exposure (8 portfolio companies) | Fund V $681M | 2025: Iconsulting majority (November 2025), Isoclima exit to Fondo Italiano consortium, Axitea exit to Argos Wityu (May 2025) |
| 21 Invest Italy | Italian + multi-country | Group AUM €1.2B; 7 active funds, 21 companies, €1.6B aggregate sales | December 2025: 21 Next platform created with Edizione + Tages (~€3B combined AUM) |
| Quadrivio Group | Italian sector-specialist | Five sector funds (Lifestyle, Lifestyle II, Industry 4.0, Silver Economy, AI PE Fund) | 2025-26: Twin-Set Simona Barbieri (June 2025), Les Secrets de Loly (March 2026), Biotec Italia 70% via Silver Economy. Portfolio: Autry, Rosantica, PROSIT |
| Nextalia SGR | Italian LMM (founded 2021) | AUM ~€2B by August 2025 | Funds: Private Equity, Credit Opportunities, Ventures, Capitale Rilancio, Flexible Capital. 2025: Westrafo (May 2025), 38.74% Tinexta stake (jointly with Advent International) |
| NB Renaissance Partners | 2015 spin-off of Intesa Sanpaolo PE with Neuberger Berman | AUM €1.8B across three funds (NBRP I, Fund III, Annex Fund) | 30 professionals Milan + Luxembourg. Recent: Tractive (March 2026) |
| Xenon Private Equity | Italian LMM | >€1.6B fundraising across 8 funds | Binding agreement to join EQUITA’s alternative asset platform (~€1B AUM). 2025: Zanetti Arturo & C (December 2025), TuttoAmbiente (July 2025); 5 acquisitions in trailing 12 months |
| Aksia Group | Italian SMEs €30-€150M revenue | AUM ~€600M; Aksia Capital VI active 2025 | 2024-25: Seasmart 100% (Nov 2025), HPILOG (July 2025). Active platforms: Content Group (ophthalmic CDMO), Valsa Group (frozen pizza, 4 add-ons), PCG (dental clinic group, 25+ clinics) |
| VAM Investments | Milan; founded 2011 | Ticket €25-€200M; majority or qualified minority | 2025: Guidi Impianti (Nov 2025), Everest (Dec 2025), Slam Spa exit (Oct 2025) |
| Green Arrow Capital + DeA Capital Alternative Funds SGR | Combined entity post-close | >€6B AUM combined, 32 funds, 7 client solutions products, 167 professionals (80 ex-DeA), 7 investment strategies | August 5, 2025 binding agreement; subject to Bank of Italy regulatory approval |
| F2i SGR (infrastructure-adjacent) | Italian infrastructure | AUM >€8.3B (2025); fund nearing €1B for Europe push (Feb 2026) | 6 sectors: transport & logistics, energy transition, circular economy, telecoms, healthcare infrastructure, distribution networks; 8 Italian airports |
CEE LMM PE operates at meaningfully smaller fund sizes than Western European peers, with heavy DFI (EBRD, IFC, European Investment Fund) co-investment and concentrated regional specialists. Invest Europe’s 2025 regional fundraising split does not isolate CEE as a standalone aggregate (likely embedded inside Southern Europe or DACH). Confidence on CEE-share gap: LOW (gap-disclosed).
| Sponsor | HQ | Latest fund | Coverage / style |
|---|---|---|---|
| Innova Capital | Warsaw | Innova/7 €407M (April 2024, +€57M over target); 7 funds cumulative €1.6B | 80+ investments across 10 CEE countries. February 2026 exit: OSHEE sold to Mid Europa Partners. August 2025 add-on: Prime Label Group acquired Arti-Bau |
| Mid Europa Partners | Pan-CEE | Fund VI target €800M, Luxembourg-domiciled (EBRD considering up to €200M LP commitment) | Ticket €50-€300M of equity. 2026 deals: OSHEE (Feb), Optika Anda majority (Croatian optical chain, Jan), RBC IT system integrator (Jan) |
| Abris Capital Partners | Warsaw + Bucharest + Nicosia | Self-described “leading ESG transformation specialist private equity investor focused on Central Europe” | Recent exits: Dot2Dot (2024), Scanmed (2024), Velvet CARE to Partners Group (2024). Active portfolio: CargoUnit, Hyperfy, Patent Co., Novago |
| Enterprise Investors | Warsaw | EIF IX final close €340M (May 6, 2025); 10 funds since 1990, €2.3B invested/committed across 160 companies, 140 exits | Commercial investors >60% (first time in 35-year history); EBRD + IFC on DFI side. EIF IX deployed: APS (anti-drone radar), eTravel, Expobud (modular housing), Scan Lab, Sescom, Unity Care. 2026 deals: Art Wind, Romanian gym chain, Unity Care add-on |
| BaltCap | Tallinn + Riga + Vilnius + Warsaw + Helsinki + Stockholm | BaltCap PE Fund III €177M hard cap; cumulative €400M+ committed, 70+ investments since 1995 | EV €10-€100M; largest Baltic PE fund. 2025: Ridango (Baltic Exit Deal of the Year 2026); Piletilevi Group’s acquisition of Ticketportal (Baltic Outbound Deal of the Year 2026) |
| Livonia Partners | Baltic | Fund II €157M final close September 2022 (vs Fund I €73M, 2015) | EV €10-€100M; ≥10% of capital into climate/sustainability projects (ESG commitment) |
| INVL Asset Management | Lithuania | AUM >€2B; INVL PE Fund II €410M (largest PE fund in Baltics); INVL Baltic Sea Growth Fund €165M | Multi-strategy (PE, forests, ag land, renewables, RE, private debt); strategic lending fund launched 2025 |
| Genesis Capital | Prague + Bratislava | GPEF V established 2025, first close €225M, hard cap €295M; GPEF IV €150M (2021) | Czechia, Slovakia, Poland, Hungary, Austria. Ticket €10-€35M. Active portfolio: GTH catering, Summa Linguae, 11 Entertainment Group, Hecht Motors, Borcad, TES Vsetin, XBS, PFX, AV Media, Schulte Group |
| ARX Equity Partners | Prague | ARX CE V first close €78M (October 2024) vs €100M target; hard cap €125M | Lower mid-cap B2B SMEs (manufacturing, business services, healthcare/education/lifestyle). EIB + EBRD commitments |
| Jet Investment | Czechia | Jet 4 Fund launched November 2025 (target up to €350M, 17% target return, 10-year horizon); Jet 3 Fund opened 2022 | Czechia, Poland, Germany, Austria, Slovakia. Strategy: medium-sized industrial company acquisitions |
| Value4Capital | Poland | V4C Poland Plus Fund II first close July 2024 €110M (vs €100M target); +20% larger than Fund I | Poland + Romania (regional expansion from Poland-only Fund I); IFC investment. 2025: Univio platform |
| Morphosis Capital | Romania | Fund II €130M (September 2025, vs Fund I €50M); EBRD €15M commitment | 9-10 investments planned, ticket €10-€15M; healthcare, B2B services, consumer/retail, niche manufacturing; CEE + Romania expansion. Platforms: Romania Education Alliance, La Cocos, EnduroSat |
| Tar Heel Capital | Warsaw | Fund IV €120M; 2025: promar.pl (July 2025) | Poland |
| BlackPeak Capital | Sofia | SEE growth equity; B Corp certified 2024-25 | Bulgaria, Romania, Balkans. 2025: Kafeterija (Serbian specialty coffee chain) |
| EOS Capital Partners | Athens (Greece) | EOS Hellenic Renaissance Fund II active; 18 investments cumulative | F&B, tourism, fintech, retail, energy efficiency, pharma. 2025 exit: Safe Life (June 2025) |
| Elikonos Capital | Athens | Elikonos 2 active | Greek mid-market. April 2025: divested Megas Yeeros to EOS HRF II |
The single most consequential structural trend in 2024-2026 is the explicit move by European mega-cap PE to add or expand LMM-focused sub-funds. This is documented across all three named research houses:
The named LMM sub-funds inside European mega-caps:
| Mega-cap sponsor | LMM sub-fund / strategy | Latest fund |
|---|---|---|
| EQT | EQT Mid Market Europe + EQT Healthcare Growth | EQT Mid Market Europe €1.6B (2016, older); EQT Healthcare Growth ~$967M |
| Bridgepoint | Bridgepoint Development Capital (BDC) | BDC V €2.8B (H1 2025); BG II €0.3B – explicit LMM arm |
| Hg | Hg Mercury (vertical software LMM) | Mercury 5 targeting €2.5B (raising) |
| Ardian | Ardian Expansion + Ardian Growth | Expansion VI active; Growth III €530M (May 2024) |
| PAI Partners | PAI Mid-Market Fund | PAI Mid-Market I ~€920M (March 2023); Fund II in market |
| Triton | Triton Smaller Mid-Cap (TSM) | TSM II €815M; TSM III ~€1B target |
| Astorg | Astorg Mid-Cap | €1.3B (February 2022 inaugural hard cap) |
| Eurazeo | Eurazeo Smid-Cap + Eurazeo PME | Eurazeo PME V >€1B first close (May 2026) |
| IK Partners | IK Small Cap | IK Small Cap IV €2.0B (July 2025) – among largest pure-play LMM funds in Europe |
| Carlyle | Carlyle Europe Technology Partners (CETP) | CETP IV €1.35B; CETP V raising |
| Thoma Bravo | Thoma Bravo Europe Fund I | €1.8B final close (February 2025) |
| Cinven | European mid-market fund (raising) | Target €1.5-€2B (announced/leaked June 2025); Dr. Michael Weber hired as mid-market partner |
Confidence: HIGH on each named LMM sub-fund. The implication for an LMM seller: in 2026 you are increasingly likely to receive credible bids from both regional LMM specialists AND mega-cap LMM sub-funds for the same deal.
The FSR entered into force 12 July 2023 with full application from 12 October 2023. M&A notification thresholds: financial contribution >€50M from non-EU country + EU turnover ≥€500M. By end-December 2025 the European Commission had received nearly 300 M&A notifications, far exceeding the initial estimate of ~30 cases per year. The first in-depth investigation concluded in 2024 (e&/PPF, approved 24 September 2024 subject to binding commitments). The first final decision under FSR’s public procurement instrument was issued April 2026 (CRRC/Lisbon). FSR Guidelines were published by the EC on 9 January 2026. Source: European Commission FSR Guidelines January 2026. Confidence: HIGH.
Implication for European LMM PE: most LMM transactions fall below the FSR thresholds, but any deal involving non-EU sovereign wealth, state-backed entities, or recipients of significant non-EU subsidies must factor in the notification trigger and review delay (typically 25 working days Phase I, extending to 90+ days in Phase II).
Adopted/entered into force 1 August 2024. Full applicability 2 August 2026 (most provisions including Articles 6-15 high-risk requirements). Phased implementation:
Source: EC AI Act regulatory framework page. Confidence: HIGH. LMM portfolio companies developing or deploying AI systems face compliance burden that scales with use-case classification; PE buyers should diligence high-risk AI classification before close.
The European Commission’s SFDR2 proposal was published 20 November 2025. Three new labels replace the Article 6 / 8 / 9 framework: “transition” / “ESG basics” / “sustainability”, with a 70% threshold for ESG-aligned assets. Significantly reduced product-level disclosures; 18-month implementation period. Source: EC DG FISMA SFDR2 proposal. Confidence: HIGH.
PE classification trends per Langham Hall and EFAMA data: Article 8 funds in PE went from ~25% of new onboardings in 2022 to 35%+ in 2023 to 40% in 2024. Article 9 funds: ~29% in 2022, ~13% in 2023, ~20% in 2024 (stabilised). CSSF Luxembourg turned ESMA’s SFDR Reality Check into concrete supervisory expectations October 2025. Confidence: MEDIUM on the share data.
The Council of the EU reached provisional agreement on 9 December 2025; European Parliament approved 16 December 2025. New thresholds raise the employee threshold to 1,000 employees + net turnover >€450M; listed SMEs removed from scope. The “Stop-the-Clock” Directive (EU) 2025/7942 postpones existing reporting requirements for Wave 2 and Wave 3 entities by two years. The LMM cascade effect remains: Wave 1 large companies still must report FY 2024 in 2025, and supply-chain reporting cascades to LMM suppliers and portfolio companies. Source: Council of the EU CSRD/CSDDD provisional agreement (December 9 2025). Confidence: HIGH.
Material 2025-2026 changes affecting GP economics across Europe:
| Jurisdiction | Carried interest treatment 2026 | Source |
|---|---|---|
| UK | From 6 April 2026: carried interest moves from CGT to income tax + Class 4 NICs. “Qualifying” carry (40-month weighted hold) taxed on 72.5% of total – effective rate 34.075%. Non-qualifying carry up to 47%. UK Autumn Budget 2024 raised the interim CGT rate to 32% | Mayer Brown, Saffery, UK Treasury |
| Italy | Carried interest presumed financial income / capital gain at 26% substitute tax (vs marginal income tax up to 43%) if three conditions met: managers’ commitment ≥1% of overall investment, hurdle = full LP capital + preferred return, instruments held ≥5 years | Withers, Bird & Bird, Pirola Pennuto Zei |
| France / Germany / Spain | Qualifying carry typically 25-30% (Baker McKenzie + Hogan Lovells comparative survey) | MEDIUM |
| Netherlands | Motion adopted to increase carried interest income tax rate to 36% from 1 January 2026 | KPMG TaxNewsFlash |
Confidence: HIGH on UK + Italy + Netherlands; MEDIUM on France / Germany / Spain (no statute-level primary source extracted in this research wave). Sweden rate gap-disclosed. Implication: UK GP economics are tightening fastest; expect continued GP migration to lower-tax European hubs (Luxembourg, Switzerland) for new fund formations.
Material 2024-2026 European PE-backed IPOs (verified primary sources):
| Company | Date | Exchange | PE Sponsor(s) | Size / Valuation | Outcome |
|---|---|---|---|---|---|
| Galderma | 22 March 2024 | SIX Swiss Exchange | EQT (consortium) | CHF 2.3B raised; CHF 15B (~$17B) mkt cap day 1 | Completed; EQT fully exited March 2026 via record CHF block trade |
| Renk Group | 7 February 2024 | Frankfurt | Triton | €750M pre-IPO; €6B+ later 2024 | Completed; Triton fully exited 2024 at 7x return |
| Douglas AG | 21 March 2024 | Frankfurt | CVC + Kreke family | €2.8B mkt cap; ~€800M new equity + €300M from CVC/family | Completed; CVC retained majority |
| CVC Capital Partners | 26 April 2024 | Euronext Amsterdam | Self-listing | €2.3B IPO; opened €17.34 vs €14 offer | Completed |
| Springer Nature | 4 October 2024 | Frankfurt | BC Partners + Holtzbrinck | €22.50; €4.5B equity value; ~€600M proceeds | Completed; BC Partners retained ~36% |
| HBX Group (Hotelbeds) | 13 February 2025 | Spanish Stock Exchange | EQT, Cinven, CPP Investments | €11.50; €2.84B / $2.93B valuation; €748M raised – largest European IPO of 2025 to that point | Completed; all three sponsors retained minority stakes |
| Verisure | 8 October 2025 | Nasdaq Stockholm | Hellman & Friedman | €13.25/share; €13.7B total mkt cap; gross primary proceeds ~€3.1B + secondary ~€55M; up to ~€3.6B incl. greenshoe | Completed – “largest-ever European private equity-backed IPO” per Latham & Watkins |
| Visma | Q1/Q2 2026 expected | London (planned) | Hg | ~€19B targeted | In progress; 11+ banks engaged December 2025 |
| Novobanco | Q2 2026 target | Lisbon | Lone Star | Up to €7B valuation | In progress |
| Golden Goose | June 2024 | Milan (planned) | Permira | <€2B targeted | Pulled at last minute |
| Stada | n/a | Frankfurt (planned) | Bain Capital + Cinven | n/a | Pulled 2025; sold to CapVest 2025 |
Total 2024 European PE-backed IPO proceeds: €14.6B from 57 IPOs (vs €7.2B in 2023, combined PE + non-PE). Stockholm led European 2025 by IPO activity ($6.8B raised). The Verisure IPO is the high-water mark for European PE-backed exits.
Cross-border exit pattern: US strategic buyers = ~1/3 of European PE exits, with US sponsors representing ~1 in 5 European deals in 2025 (predicted ~1 in 4 in 2026 per Bain + Ropes & Gray). Tech, IT services, and healthcare dominate cross-border sectors. Energy, automotive, and chemicals under tariff pressure.
The combined named LMM sub-funds at European mega-caps now exceed €15B in dedicated capital (Bridgepoint BDC V €2.8B + Hg Mercury 5 raising €2.5B + IK Small Cap IV €2.0B + Thoma Bravo Europe €1.8B + Carlyle Europe Tech IV €1.35B + Astorg Mid-Cap €1.3B + Eurazeo PME V first close >€1B + PAI Mid-Market €920M + Cinven raising €1.5-2B). PitchBook + ION confirm KKR, EQT, CVC, and Permira have dropped average global deal sizes vs 2021. For LMM sellers in 2026, the buyer set has expanded structurally, not contracted. Confidence: HIGH.
Per BVCA Performance Measurement Survey 2024: UK Small PE returned 9.0% in 2024 vs UK Large PE at 2.4%, with Mid PE at 0.7% and VC at -3.0%. The 2024 LMM outperformance is the largest segment-level gap in recent vintage data. The structural explanation: smaller portfolio companies were less exposed to subdued exit market for larger investments. Confidence: HIGH.
Per Invest Europe and Argos Mid-Market Index: 2025 fundraising €147B (+16% YoY, second only to 2022’s record), continuation funds €19.8B (more than 2x 2024’s €9.3B), but Q4 2025 Argos median EV/EBITDA hit 8.3x, the lowest level since H1 2014. The bifurcation: LPs are funding new vintages while deal-pricing discipline tightens. Implication for LMM sellers: prepared, high-quality assets command premium pricing in a compressed-multiple market; lower-quality assets face fewer bidders. Confidence: HIGH.
The Stockholm-listed permanent-capital LMM acquirer holds 114 business units across ~30 countries, ran SEK 33.1B revenue in 2025, and offers Nordic SMEs a buyer that does not have a fund-end clock. Storskogen 2025 deal pace: 3 platforms + 6 add-ons. Comparable models exist in Belgium (Ackermans & van Haaren / Sofinim, Indufin) and Netherlands (NPM Capital / Egeria Evergreen) but none at Storskogen’s listed, permanent-capital scale. For an LMM owner who values brand preservation and indefinite hold horizon over headline multiple, the permanent-capital tier deserves explicit consideration. Confidence: HIGH.
Per Argos Q1 2026: PE buyers paid 10.0x EV/EBITDA while strategic buyers paid 7.8x. The spread widened from 1.0x in late 2024 to 2.2x in Q1 2026, with PE pricing aggressively for high-quality LMM assets while strategics tightened synergy underwriting. This is the same inversion we documented for US insurance brokerage M&A; it now extends to European LMM. Confidence: HIGH. Implication: dual-track processes (PE + strategic in parallel) may not produce the strategic premium of pre-2022 vintages.
The FSR notifications surge (300 by end-2025 vs 30 expected annually) primarily catches large-cap deals. The EU AI Act, CSRD Omnibus, and SFDR2 cascade down into LMM portfolio company compliance burden, not into PE fund structure. CSRD’s supply-chain cascade means a sub-€25M-revenue LMM portfolio company supplying a Wave 1 large company must produce CSRD-compliant data starting FY 2024 reports. AI Act high-risk classification creates portfolio diligence load. Source quality: HIGH on the regulatory facts; MEDIUM on the structural read that LMM PCs bear most of the compliance weight.
No single buyer tier dominates across all seller profiles. The right match is a function of (a) target EV scale, (b) country/region, (c) sector, (d) succession willingness, (e) brand preservation preference, (f) cash-vs-rollover preference. Confidence on this matrix: MEDIUM (directional framework, not a primary-source outcome survey).
| Seller profile | Typically best fit | Why |
|---|---|---|
| Sub-€20M EV LMM owner, single-country | Regional specialist (e.g., Vaaka in Finland, Apiary or WestBridge in UK, Diana in Spain, Aksia in Italy, Sponsor Capital in Finland) | Sponsor mandate exactly matches deal size; regional sourcing networks |
| €20-€100M EV LMM, single country | Country-flagship LMM specialist (e.g., Inflexion / August / Bowmark in UK, Andera MidCap / Activa in France, Adelis in Sweden, Waterland in Benelux, Portobello / Nazca in Spain) | Sweet spot of national flagship LMM funds |
| €100-€500M EV mid-market or pan-European | Mega-cap LMM sub-fund (Bridgepoint BDC, Hg Mercury, IK Small Cap, Triton TSM, Astorg Mid-Cap, PAI Mid-Market, Eurazeo PME) | Capital scale + cross-border integration capability |
| Founder wants permanent capital / brand preservation | Storskogen (Nordics), Ackermans & van Haaren (Belgium), NPM Capital (Netherlands), Egeria Evergreen, Smile Invest, Indufin, Italmobiliare (Italy), Bpifrance (France state-backed) | Permanent capital and evergreen structures preserve brand and culture indefinitely |
| ESG / impact / climate focus | Ambienta (Italy), Trill Impact (Sweden), Mentha Impact (Netherlands), Bridges Climate Transition (UK), Tikehau Decarbonization, Argos Climate Action, Bpifrance Tomorrow (France) | Dedicated impact vehicles with Article 9 or near-Article 9 classifications |
| Family business succession in DACH/France/Italy/Spain | Family-office-friendly platforms (Adelis, Naxicap, Sherpa, NB Renaissance, 21 Invest, Sofindev, Indufin, Realza) | Sponsor mandate explicit on family-business succession; relationship-led sourcing |
| Sector-specialty seller (cyber, healthtech, climate) | Sector-specialist sponsors (Hg for software, Thoma Bravo Europe for software, Ambienta for climate, Tikehau for climate/cyber, Quadrivio AI PE Fund for AI) | Sector expertise + pre-built buy-and-build playbooks |
| Cross-border European platform seller | Pan-European mid-cap specialists (IK Mid Cap, Triton T6, Bridgepoint Europe VII, Cinven, Permira, EQT X) | Multi-country execution capability + cross-border value creation |
Every numerical claim above is sourced to a primary firm publication, regulator, peer-reviewed research publisher, or named industry research source.
Last verified: June 6, 2026. Next refresh: quarterly, or on the next major European PE sponsor transition / EU regulatory milestone, whichever is sooner.
Disclaimer: This article is general buyer-landscape and macro-research intelligence, not investment, legal, or tax advice. Sponsor structures, transaction terms, and regulatory positions are point-in-time and reflect publications current at the date of publication. CT Acquisitions is a buy-side advisor.